Simplify Logo

Full-Time

Senior Director Commercial Effectiveness and Training

Posted on 6/27/2024

Acadia Pharmaceuticals Inc.

Acadia Pharmaceuticals Inc.

501-1,000 employees

Develops therapies for neurological disorders

Consulting
Biotechnology

Compensation Overview

$213k - $266.5kAnnually

+ Bonus + Equity Awards

Expert

San Diego, CA, USA

Category
Customer Success Management
Sales & Account Management
Required Skills
Sales
Communications
Management
Requirements
  • Bachelor’s degree (science or business preferred) or equivalent
  • MBA preferred
  • Minimum of 15 years progressively responsible experience in pharmaceutical or medical sales and training
  • Minimum of 6 years in a training or sales leadership role
  • Experience in neuroscience preferred
  • Prior pharmaceutical sales experience
  • First-line pharmaceutical/biotech sales management experience
  • Vendor and contract management experience
  • Experience with product launches
  • Long-Term Care and Account Management experience desired
  • Demonstrated leadership and teaching/facilitation ability
  • Proven ability in creating effective sales training materials
  • Proven application of adult learning principles
  • Excellent interpersonal and communication skills
  • Project and vendor management experience
  • Ability to travel up to 30% overnight
Responsibilities
  • Developing and maintaining commercial training curriculum and on-boarding processes
  • Overseeing the development, updating, and use of training modules
  • Creating training materials to enhance learning process
  • Leading training of field commercial employees
  • Gathering and analyzing data to identify training gaps
  • Managing training of field staff on sales-related tools
  • Planning sales meetings and developing necessary workshops
  • Facilitating management-level 'train-the-trainer' sessions
  • Owning the ACADIA Selling Model
  • Assisting with field coaching, recruiting, and interviewing
  • Partnering in building a career development infrastructure
  • Managing Learning Management System and vendors
  • Ensuring field commercial employees are trained on policies and procedures
  • Developing and executing Field colleague Emerging Leaders Program
  • Working with Commercial Leadership on training initiatives
Acadia Pharmaceuticals Inc.

Acadia Pharmaceuticals Inc.

View

Acadia Pharmaceuticals develops therapies for neurological disorders, focusing on conditions like Parkinson's disease, schizophrenia, and Rett syndrome. Their products are created through extensive research and development, followed by rigorous clinical trials to ensure safety and effectiveness. Once approved by regulatory bodies like the FDA, these therapies are marketed to patients and healthcare providers. Acadia stands out from competitors by concentrating on areas with significant unmet medical needs and fostering strategic partnerships to enhance their research and market presence. The company's goal is to improve the quality of life for individuals with neurological conditions through effective treatments.

Company Stage

IPO

Total Funding

$813.4M

Headquarters

Dallas, Texas

Founded

1993

Simplify Jobs

Simplify's Take

What believers are saying

  • Acadia's launch of Magnolia's Guide to Adventuring showcases their innovative approach to raising disease awareness and redefining perceptions of Rett syndrome.
  • The acceptance of trofinetide for priority review by Health Canada could lead to significant market expansion and first-mover advantage in treating Rett syndrome in Canada.
  • The appointment of Dr. Elizabeth H. Z. Thompson as Executive Vice President, Head of Research and Development, signals a strong commitment to advancing their R&D capabilities.

What critics are saying

  • The failure of the Phase III ADVANCE-2 trial for pimavanserin in schizophrenia highlights the high-risk nature of drug development in the biopharmaceutical sector.
  • Dependence on regulatory approvals, such as the FDA and Health Canada, introduces uncertainty and potential delays in bringing therapies to market.

What makes Acadia Pharmaceuticals Inc. unique

  • Acadia Pharmaceuticals focuses exclusively on neurological disorders, setting it apart from competitors with broader therapeutic areas.
  • Their commitment to corporate social responsibility, including initiatives like the Rett Sibling Scholarship, enhances their reputation and community engagement.
  • Acadia's strategic partnerships and corporate sponsorships amplify their research capabilities and market reach, distinguishing them from competitors who may not leverage such collaborations.
INACTIVE